WebDisclosure WebDisclosure
Basculer en Français
9502 Companies
186411 Keywords
118646 Articles
99762 Press releases
Headlines Articles Press releases NTC Srl Remove
  1. Home
  2. Companies
  3. NTC Srl
WebDisclosure
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 12/10/2025 at 10:10, 2 hours 21 minutes ago

    NTC Acquires Pharmathen's Ophthalmology Business

    International Expansion Ophthalmology NTC Acquisition Wise Equity Support Glaucoma Treatments
  • BRIEF

    published on 12/10/2025 at 10:10, 2 hours 21 minutes ago

    NTC acquiert l'activité ophtalmologique de Pharmathen

    Expansion Internationale Ophtalmologie Acquisition De NTC Soutien Wise Equity Traitements Du Glaucome
  • PRESS RELEASE

    published on 12/10/2025 at 10:05, 2 hours 26 minutes ago

    NTC, BACKED BY WISE EQUITY, COMPLETES THE ACQUISITION OF PHARMATHEN'S OPHTHALMOLOGY BUSINESS

    NTC, backed by Wise Equity, completes the acquisition of Pharmathen's ophthalmology business, expanding their glaucoma portfolio and international presence
    Acquisition Glaucoma Ophthalmology NTC Wise Equity
    Logo of NTC Srl
Accesswire
  • Published on 12/10/2025 at 10:00, 2 hours 31 minutes ago

    Linear Minerals Corp. acquires the Kipawa West Rare Earth Project, Quebec

  • Published on 12/10/2025 at 07:55, 4 hours 36 minutes ago

    Nordex Group and Alliant Energy Team Up to Increase Manufacturing Jobs and Wind Production in Iowa

  • Published on 12/10/2025 at 00:00, 12 hours 31 minutes ago

    Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care

  • Published on 12/09/2025 at 23:20, 13 hours 11 minutes ago

    SMX Announces Amendment to $111.5M Equity Purchase Agreement

  • Published on 12/09/2025 at 22:30, 14 hours 1 minute ago

    Grande Portage Closes C$5Million Equity Raise

View all ACCESSWIRE
EQS Group
  • Published on 12/10/2025 at 12:05, 26 minutes ago

    Bendit Announces FDA Clearance for the Bendit17™ Steerable Microcatheter

  • Published on 12/10/2025 at 12:05, 26 minutes ago

    Finnish Nuclear Ship Startup SEATOM Selected for NATO's Accelerator Programme

  • Published on 12/10/2025 at 11:39, 51 minutes ago

    Elmos Semiconductor SE opens new development site in Brno, Czechia, and strengthens global R&D network for innovative future projects

  • Published on 12/10/2025 at 11:25, 1 hour 6 minutes ago

    Original-Research: MaaT Pharma SACA (von First Berlin Equity Research GmbH): BUY

  • Published on 12/10/2025 at 10:05, 2 hours 26 minutes ago

    NTC, BACKED BY WISE EQUITY, COMPLETES THE ACQUISITION OF PHARMATHEN'S OPHTHALMOLOGY BUSINESS

View all EQS
Les Echos
  • Published on 12/10/2025 at 08:00, 4 hours 31 minutes ago

    Neoen delivers Western Downs Battery Stage 2 and launches Stage 3 in Queensland, Australia

  • Published on 12/10/2025 at 08:00, 4 hours 31 minutes ago

    Neoen met en service la 2ème tranche et lance la construction de la 3ème tranche de Western Downs Battery dans le Queensland, en Australie

  • Published on 12/10/2025 at 07:00, 5 hours 31 minutes ago

    EURAZEO WILL ACQUIRE A MAJORITY STAKE IN WATER DIRECT TO SUPPORT NEXT PHASE OF GROWTH

  • Published on 12/10/2025 at 07:00, 5 hours 31 minutes ago

    EURAZEO VA ACQUERIR UNE PARTICIPATION MAJORITAIRE DANS WATER DIRECT POUR SOUTENIR LA PROCHAINE PHASE DE CROISSANCE

  • Published on 12/09/2025 at 18:16, 18 hours 15 minutes ago

    AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 30/11/2025

View all LES ECHOS COMFI WIRE

With webdisclosure.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

©Dissemination technology Webdisclosure.com - copyright 2025 SYMEX ECONOMICS all rights reserved

WebDisclosure

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

Contact Authors Cookies policy Terms and conditions Privacy policy